|
1
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006–2010. Neuro Oncol. 15
Suppl 2:ii1–ii56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Westphal M and Lamszus K: The neurobiology
of gliomas: From cell biology to the development of therapeutic
approaches. Nat Rev Neurosci. 12:495–508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Mason WP, Van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tanaka S, Louis DN, Curry WT, Batchelor TT
and Dietrich J: Diagnostic and therapeutic avenues for
glioblastoma: No longer a dead end? Nat Rev Clin Oncol. 10:14–26.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gilbert MR, Dignam JJ, Armstrong TS, Wefel
JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S,
Won M, et al: A randomized trial of bevacizumab for newly diagnosed
glioblastoma. N Engl J Med. 370:699–708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun Y, Zhang W, Chen D, Lv Y, Zheng J,
Lilljebjorn H, Ran L, Bao Z, Soneson C, Sjogren HO, et al: A glioma
classification scheme based on coexpression modules of EGFR and
PDGFRA. Proc Natl Acad Sci USA. 111:pp. 3538–3543. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yan W, Zhang W, You G, Zhang J, Han L, Bao
Z, Wang Y, Liu Y, Jiang C, Kang C, et al: Molecular classification
of gliomas based on whole genome gene expression: A systematic
report of 225 samples from the Chinese Glioma Cooperative Group.
Neuro Oncol. 14:1432–1440. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao YF, Mao XY, Zhu T, Mao CX, Liu ZX,
Wang ZB, Li L, Li X, Yin JY, Zhang W, et al: COL3A1 and SNAP91:
Novel glioblastoma markers with diagnostic and prognostic value.
Oncotarget. 7:70494–70503. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi Y, Chen C, Zhang X, Liu Q, Xu JL,
Zhang HR, Yao XH, Jiang T, He ZC, Ren Y, et al: Primate-specific
miR-663 functions as a tumor suppressor by targeting PIK3CD and
predicts the prognosis of human glioblastoma. Clin Cancer Res.
20:1803–1813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Meng J, Li P, Zhang Q, Yang Z and Fu S: A
radiosensitivity gene signature in predicting glioma prognostic via
EMT pathway. Oncotarget. 5:4683–4693. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meng D, Chen Y, Yun D, Zhao Y, Wang J, Xu
T, Li X, Wang Y, Yuan L, Sun R, et al: High expression of N-myc
(and STAT) interactor predicts poor prognosis and promotes tumor
growth in human glioblastoma. Oncotarget. 6:4901–4919. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cancer Genome Atlas Research Network, .
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rutledge WC, Kong J, Gao J, Gutman DA,
Cooper LA, Appin C, Park Y, Scarpace L, Mikkelsen T, Cohen ML, et
al: Tumor-infiltrating lymphocytes in glioblastoma are associated
with specific genomic alterations and related to transcriptional
class. Clin Cancer Res. 19:4951–4960. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin Y, Chen Y, Wang Y, Yang J, Zhu VF, Liu
Y, Cui X, Chen L, Yan W, Jiang T, et al: ZIP4 is a novel molecular
marker for glioma. Neuro Oncol. 15:1008–1016. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Meng D, Wang H, Sun R, Wang D,
Wang S, Fan J, Zhao Y, Wang J, Yang S, et al: VAMP8 facilitates
cellular proliferation and temozolomide resistance in human glioma
cells. Neuro Oncol. 17:407–418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Silacci P, Mazzolai L, Gauci C,
Stergiopulos N, Yin HL and Hayoz D: Gelsolin superfamily proteins:
Key regulators of cellular functions. Cell Mol Life Sci.
61:2614–2623. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Van Impe K, De Corte V, Eichinger L,
Bruyneel E, Mareel M, Vandekerckhove JL and Gettemans J: The
nucleo-cytoplasmic actin-binding protein CapG lacks a nuclear
export sequence present in structurally related proteins. J Biol
Chem. 278:17945–17952. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Witke W, Li W, Kwiatkowski DJ and
Southwick FS: Comparisons of CapG and gelsolin-null macrophages:
Demonstration of a unique role for CapG in receptor-mediated
ruffling, phagocytosis, and vesicle rocketing. J Cell Biol.
154:775–784. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dahl E, Sadr-Nabavi A, Klopocki E, Betz B,
Grube S, Kreutzfeld R, Himmelfarb M, An HX, Gelling S, Klaman I, et
al: Systematic identification and molecular characterization of
genes differentially expressed in breast and ovarian cancer. J
Pathol. 205:21–28. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fan S, Meng D, Xu T, Chen Y, Wang J, Li X,
Chen H, Lu D, Chen J and Lan Q: Overexpression of SLC7A7 predicts
poor progression-free and overall survival in patients with
glioblastoma. Med Oncol. 30:3842013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kononen J, Bubendorf L, Kallioniemi A,
Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G
and Kallioniemi OP: Tissue microarrays for high-throughput
molecular profiling of tumor specimens. Nat Med. 4:844–847. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ohuchida K, Mizumoto K, Ishikawa N, Fujii
K, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M and Tanaka M: The
role of S100A6 in pancreatic cancer development and its clinical
implication as a diagnostic marker and therapeutic target. Clin
Cancer Res. 11:7785–7793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Malliri A, Van Es S, Huveneers S and
Collard JG: The Rac exchange factor Tiam1 is required for the
establishment and maintenance of cadherin-based adhesions. J Biol
Chem. 279:30092–30098. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lois C, Hong EJ, Pease S, Brown EJ and
Baltimore D: Germline transmission and tissue-specific expression
of transgenes delivered by lentiviral vectors. Science.
295:868–872. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li X, Wan XC, Chen HB, Yang S, Liu YY, Mo
WJ, Meng DL, Du WT, Huang Y, Wu H, et al: Identification of
miR-133b and RB1CC1 as independent predictors for biochemical
recurrence and potential therapeutic targets for prostate cancer.
Clin Cancer Res. 20:2312–2325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Verhaak RG, Hoadley KA, Purdom E, Wang V,
Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al:
Integrated genomic analysis identifies clinically relevant subtypes
of glioblastoma characterized by abnormalities in PDGFRA, IDH1,
EGFR, and NF1. Cancer Cell. 17:98–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brennan CW, Verhaak RG, McKenna A, Campos
B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ,
Berman SH, et al: The somatic genomic landscape of glioblastoma.
Cell. 155:462–477. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kato J, Matsushime H, Hiebert SW, Ewen ME
and Sherr CJ: Direct binding of cyclin-D to the retinoblastoma
gene-product (prb) and pRb phosphorylation by the cyclin
D-dependent kinase Cdk4. Genes Dev. 7:331–342. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lundberg AS and Weinberg RA: Functional
inactivation of the retinoblastoma protein requires sequential
modification by at least two distinct cyclin-cdk complexes. Mol
Cell Biol. 18:753–761. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Weinberg RA: The retinoblastoma protein
and cell-cycle control. Cell. 81:323–330. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Francis JM, Zhang CZ, Maire CL, Jung J,
Manzo VE, Adalsteinsson VA, Homer H, Haidar S, Blumenstiel B,
Pedamallu CS, et al: EGFR variant heterogeneity in glioblastoma
resolved through single-nucleus sequencing. Cancer Discov.
4:956–971. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li C, Lei B, Huang S, Zheng M, Liu Z, Li Z
and Deng Y: H19 derived microRNA-675 regulates cell proliferation
and migration through CDK6 in glioma. Am J Transl Res. 7:1747–1764.
2015.PubMed/NCBI
|
|
35
|
Hall A: The cytoskeleton and cancer.
Cancer Metastasis Rev. 28:5–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu JH, Tian XY and Hao CY: The
significance of a group of molecular markers and
clinicopathological factors in identifying colorectal liver
metastasis. Hepatogastroenterology. 58:1182–1188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li T, Hong X, Zhao J, Teng Y, Zheng J,
Chen H, Chen H and Li H: Gelsolin-like actin-capping protein is
associated with patient prognosis, cellular apoptosis and
proliferation in prostate cancer. Biomark Med. 10:1251–1260. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shao F, Zhang R, Dong L and Ying K:
Overexpression of gelsolin-like actin-capping protein is associated
with progression of lung adenocarcinoma. Tohoku J Exp Med.
225:95–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu WY, Hunag YY, Liu XG, He JY, Chen DD,
Zeng F, Zhou JH and Zhang YK: Prognostic evaluation of CapG,
gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung
cancer. Anat Rec. 295:208–214. 2012. View Article : Google Scholar
|
|
40
|
Thompson CC, Ashcroft FJ, Patel S, Saraga
G, Vimalachandran D, Prime W, Campbell F, Dodson A, Jenkins RE,
Lemoine NR, et al: Pancreatic cancer cells overexpress gelsolin
family-capping proteins, which contribute to their cell motility.
Gut. 56:95–106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hubert T, Van Impe K, Vandekerckhove J and
Gettemans J: The F-actin filament capping protein CapG is a bona
fide nucleolar protein. Biochem Biophys Res Commun. 377:699–704.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kang S, Kim MJ, An H, Kim BG, Choi YP,
Kang KS, Gao MQ, Park H, Na HJ, Kim HK, et al: Proteomic molecular
portrait of interface zone in breast cancer. J Proteome Res.
9:5638–5645. 2010. View Article : Google Scholar : PubMed/NCBI
|
